These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 33608417)

  • 21. Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study.
    Domenighetti C; Sugier PE; Ashok Kumar Sreelatha A; Schulte C; Grover S; Mohamed O; Portugal B; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Duga S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Kawamura Y; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Correia Guedes L; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen NL; Ran C; Belin AC; Puschmann A; Hellberg C; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Krüger R; Gasser T; Sharma M; Elbaz A;
    Mov Disord; 2022 Apr; 37(4):857-864. PubMed ID: 34997937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study.
    Domínguez-Baleón C; Ong JS; Scherzer CR; Rentería ME; Dong X
    Sci Rep; 2021 Jul; 11(1):13980. PubMed ID: 34234189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Caffeine Levels and Risk of Alzheimer's Disease and Parkinson's Disease: Mendelian Randomization Study.
    Larsson SC; Woolf B; Gill D
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between telomere length and Parkinson's disease: a Mendelian randomization study.
    Chen R; Zhan Y
    Neurobiol Aging; 2021 Jan; 97():144.e9-144.e11. PubMed ID: 32829966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of causality between ADHD and Parkinson's disease: Mendelian randomization study.
    Li GH; Ge GM; Cheung CL; Ip P; Coghill D; Wong IC
    Eur Neuropsychopharmacol; 2020 Aug; 37():49-63. PubMed ID: 32565043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.
    Vandebergh M; Becelaere S; ; Dubois B; Goris A
    Front Immunol; 2022; 13():834644. PubMed ID: 35386698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study.
    Hartwig FP; Borges MC; Horta BL; Bowden J; Davey Smith G
    JAMA Psychiatry; 2017 Dec; 74(12):1226-1233. PubMed ID: 29094161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study.
    Yuan S; Carter P; Bruzelius M; Vithayathil M; Kar S; Mason AM; Lin A; Burgess S; Larsson SC
    EBioMedicine; 2020 Sep; 59():102956. PubMed ID: 32805626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases.
    Zhang N; Wang Z; Zhao Y
    Cytokine Growth Factor Rev; 2020 Oct; 55():80-85. PubMed ID: 32327345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetically Predicted Milk Intake and Risk of Neurodegenerative Diseases.
    Zhang Z; Wang M; Yuan S; Larsson SC; Liu X
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively.
    Sashio H; Tamura K; Ito R; Yamamoto Y; Bamba H; Kosaka T; Fukui S; Sawada K; Fukuda Y; Tamura K; Satomi M; Shimoyama T; Furuyama J
    Immunogenetics; 2002 Mar; 53(12):1020-7. PubMed ID: 11904678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unhealthy Behaviours and Risk of Parkinson's Disease: A Mendelian Randomisation Study.
    Heilbron K; Jensen MP; Bandres-Ciga S; Fontanillas P; Blauwendraat C; Nalls MA; Singleton AB; Smith GD; Cannon P; Noyce AJ;
    J Parkinsons Dis; 2021; 11(4):1981-1993. PubMed ID: 34275906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
    Lu H; Wu PF; Zhang W; Liao X
    Front Immunol; 2021; 12():647588. PubMed ID: 33936066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study.
    Wu D; Wong P; Lam SHM; Li EK; Qin L; Tam LS; Gu J
    Rheumatology (Oxford); 2021 Apr; 60(4):1963-1973. PubMed ID: 33188428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipids, Apolipoproteins, and the Risk of Parkinson Disease.
    Fang F; Zhan Y; Hammar N; Shen X; Wirdefeldt K; Walldius G; Mariosa D
    Circ Res; 2019 Aug; 125(6):643-652. PubMed ID: 31382822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of causal factors for Parkinson's disease in European populations: A phenome-wide Mendelian randomisation analysis.
    Xue Z; Cheng Y; Yu Q; Wang T; Fan C; Zou Z; Zhang X
    Asia Pac J Clin Nutr; 2021 Jun; 30(2):329-339. PubMed ID: 34191436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease.
    Bank S; Julsgaard M; Abed OK; Burisch J; Broder Brodersen J; Pedersen NK; Gouliaev A; Ajan R; Nytoft Rasmussen D; Honore Grauslund C; Roug S; Galsgaard J; Sprogøe Høyer Finsen D; Lindby K; ; Sørensen J; Larsen L; Rohr Andersen M; Brandslund I; Thomassen M; Green A; Bo Bojesen A; Bek Sørensen S; Vogel U; Andersen V
    Aliment Pharmacol Ther; 2019 Apr; 49(7):890-903. PubMed ID: 30811631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital-treated infectious diseases, infection burden and risk of Parkinson disease: An observational and Mendelian randomization study.
    Zheng J; Shi W; Yang Q; Huang J; Shen J; Yin L; Zhang P; Zhang S; Yang M; Qian A; Zheng Z; Tang S
    Brain Behav Immun; 2024 Aug; 120():352-359. PubMed ID: 38897329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study.
    Nolde M; Alayash Z; Reckelkamm SL; Kocher T; Ehmke B; Holtfreter B; Baurecht H; Georgakis MK; Baumeister SE
    Front Immunol; 2023; 14():1160148. PubMed ID: 37342352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.